ID: ALA5268003

Max Phase: Preclinical

Molecular Formula: C17H12BrNO

Molecular Weight: 326.19

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc(Br)cc1)c1c[nH]c2ccccc12

Standard InChI:  InChI=1S/C17H12BrNO/c18-13-8-5-12(6-9-13)7-10-17(20)15-11-19-16-4-2-1-3-14(15)16/h1-11,19H/b10-7+

Standard InChI Key:  RVUJDYIDVJKIFK-JXMROGBWSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 326.19Molecular Weight (Monoisotopic): 325.0102AlogP: 4.83#Rotatable Bonds: 3
Polar Surface Area: 32.86Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.47CX Basic pKa: CX LogP: 4.76CX LogD: 4.76
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.54Np Likeness Score: -0.17

References

1. Guglielmi P, Mathew B, Secci D, Carradori S..  (2020)  Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors.,  205  [PMID:32920430] [10.1016/j.ejmech.2020.112650]

Source